Bernhard Fischer

Bernhard Fischer

Company: Apeptico

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Determining the Extent the Understandings Gained from Covid-19 ARDS Can Be Translated Into ARDS 2:55 pm

Read more

day: Day Two

Clinical Development of Solnatide Peptide for the Therapeutic Treatment of ARDS During the Coronavirus Pandemic 12:45 pm

Reviewing solnatide peptide and its capacity to activate pulmonary edema clearance and highlighting the molecular structure and interaction with the pulmonary ENaC channel Exploring basic characteristics of ARDS patients Vs. COVID-19 patients to illuminate whether ARDS pneumonia behaves similarly to viral/COVID pneumonia Navigating the limitation in hospital management during pandemics Delving into clinical trials to…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.